Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
400
Trial Sponsor
Clinical Trial Start Date
July 20, 2018
0Primary Completion Date
August 15, 2018
0Study Completion Date
August 15, 2018
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Drug0
Intervention Name
Probenecid0
vadadustat0
Rifampin0
Cyclosporins0
Interventional Trial Phase
Phase 10
Official Name
A Phase 1, Two-Part, Open-label Study in Healthy Adult Volunteers to Assess a Single Dose of Vadadustat as a Victim in Drug-Drug Interactions With Cyclosporine, Probenecid and Rifampin0
Last Updated
March 22, 2019
0Allocation Type
Randomized0
Intervention Model
Sequential Assignment0
Masking Type
None (Open Label)0
Study summary
This is a Phase 1, two-part, open-label study to evaluate the interaction of cyclosporine, probenecid, and rifampin as perpetrators with vadadustat (victim) in healthy male and female subjects.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
